PMC:7377212 / 17866-18815
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T138 | 10-21 | NCBITaxon:5052 | denotes | D-glucan (B |
T139 | 206-211 | CHEBI:68452;CHEBI:68452 | denotes | the d |
T140 | 264-269 | UBERON:0001977 | denotes | t be |
T141 | 396-401 | UBERON:0001977 | denotes | nts, |
T142 | 402-413 | NCBITaxon:5052 | denotes | nd performa |
T143 | 414-421 | CHEBI:59132;CHEBI:59132 | denotes | ce in C |
T144 | 659-662 | PR:Q8LFX7 | denotes | cop |
T145 | 872-883 | NCBITaxon:5052 | denotes | to utilise |
T146 | 884-891 | CHEBI:59132;CHEBI:59132 | denotes | ther mo |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T47 | 35-40 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T48 | 168-173 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T44 | 35-40 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T45 | 168-173 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
551 | 391-399 | Species | denotes | patients | Tax:9606 |
552 | 510-517 | Species | denotes | patient | Tax:9606 |
553 | 174-185 | Species | denotes | Aspergillus | Tax:746128 |
554 | 680-691 | Species | denotes | Aspergillus | Tax:746128 |
555 | 2-18 | Chemical | denotes | (1–3)-β-D-glucan | MESH:C480180 |
556 | 20-23 | Chemical | denotes | BDG | |
557 | 244-247 | Chemical | denotes | BDG | |
558 | 450-453 | Chemical | denotes | BDG | |
559 | 785-788 | Chemical | denotes | BDG | |
560 | 938-941 | Chemical | denotes | BDG | |
561 | 286-295 | Disease | denotes | infection | MESH:D007239 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T189 | 286-295 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T190 | 368-390 | Disease | denotes | invasive aspergillosis | http://purl.obolibrary.org/obo/MONDO_0000240 |
T191 | 377-390 | Disease | denotes | aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
T192 | 420-424 | Disease | denotes | CAPA | http://purl.obolibrary.org/obo/MONDO_0007163 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T158 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T159 | 25-29 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T160 | 33-34 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T161 | 87-91 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T162 | 106-107 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T163 | 194-201 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T164 | 302-303 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T165 | 338-339 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T166 | 482-483 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T167 | 550-555 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T168 | 596-597 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T169 | 668-675 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T170 | 719-721 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
T171 | 914-919 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T274 | 12-18 | Chemical | denotes | glucan | http://purl.obolibrary.org/obo/CHEBI_37163 |
T275 | 121-124 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T277 | 186-193 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
T278 | 223-226 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T280 | 692-699 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
T281 | 741-751 | Chemical | denotes | antifungal | http://purl.obolibrary.org/obo/CHEBI_35718 |
MyTest
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32703771-27475024-29390919 | 239-241 | 27475024 | denotes | 33 |
32703771-21880959-29390920 | 719-721 | 21880959 | denotes | 34 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T92 | 0-125 | Sentence | denotes | A (1–3)-β-D-glucan (BDG) test on a serum sample is an easily obtained, early screening test when there is a suspicion of IPA. |
T93 | 126-449 | Sentence | denotes | Although performance might be superior to serum Aspergillus antigen testing for the detection of IPA in the ICU [33], BDG negativity cannot be used to rule out infection, with a 77% sensitivity determined across a heterogeneous population of invasive aspergillosis patients, and performance in CAPA as yet to be determined. |
T94 | 450-723 | Sentence | denotes | BDG positivity can occur due to a number of reasons in this patient cohort, however serial positive tests increases specificity and should prompt a diagnostic work-up including computed tomography and bronchoscopy and testing for Aspergillus antigen as outlined above [34]. |
T95 | 724-949 | Sentence | denotes | While initiating antifungal treatment pre-emptively based on BDG positivity may be an improvement on empirical therapy, every effort should be made to utilise other more specific diagnostic tests to complement the BDG result. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32703771-27475024-29390919 | 239-241 | 27475024 | denotes | 33 |
32703771-21880959-29390920 | 719-721 | 21880959 | denotes | 34 |